Longevity

Longevity distinguishes between lifespan and healthspan. A predominantly observational meta-analysis links strength training to lower mortality, whilst randomised trials in older adults show increased leg strength and greater femoral and hip bone density. A causal extension of life or healthspan and the effects of extreme bodybuilding have not been demonstrated.

Auch bekannt als: Langlebigkeit, Healthspan, Anti-Aging, Lifespan

Knowledge Bodybuilding Bible

What “Longevity” encompasses

“Lifespan” refers to the lifespan. “Healthspan,” on the other hand, describes the years of healthy functioning. The classification includes disease burden, physical disability and dementia.

The two variables must not be equated: In population-based trend data, increased life expectancy did not automatically lead to a corresponding compression of morbidity. Behavioral, lifestyle and policy changes can improve health and life expectancy, but the data does not support an individual exercise or nutrition plan.

What links strength training to mortality

A meta-analysis with predominantly prospective observational data included ten studies in adults from non-clinical populations aged 18 years and over. The follow-up times of the individual studies were heterogeneous. Any resistance training activity was associated with lower all-cause mortality compared to no activity. The relative risks reported were RR 0.85 for all-cause mortality, RR 0.81 for cardiovascular mortality and RR 0.86 for cancer mortality. The corresponding 95% confidence intervals were 0.77 to 0.93, 0.66 to 1.00 and 0.78 to 0.95. The interval of cardiovascular estimation thus extended up to the value for no difference.

A dose analysis from just four studies in this evaluation observed the greatest risk reduction with around 60 minutes of strength training per week: 27 percent or RR 0.74 with a 95% confidence interval of 0.64 to 0.86. With higher training volumes, the observed risk reductions were smaller. Because of the predominantly observational design, the heterogeneous follow-up times, and the small base of the dose analysis, this is not a training prescription or evidence that a specific volume increases lifespan.

Observed mortality associations by resistance training amount
Ten included studies, non-clinical adults aged 18 years and over
All-cause mortality All-cause mortality: 0.85, range 0.77 to 0.93 Overall mortality: 0.85 0.85 Cardiovascular mortality Cardiovascular mortality: 0.81, interval 0.66 to 1 Cardiovascular mortality: 0.81 0.81 cancer mortality Cancer mortality: 0.86, interval 0.78 to 0.95 Cancer mortality: 0.86 0.86 About 60 minutes per week separate dose analysis, four studies About 60 minutes per week: 0.74, interval 0.64 to 0.86 About 60 minutes per week: 0.74 0.74 0.6 0.7 0.8 0.9 1 1.1 Relative risk
Meta-analytic relative risks from predominantly prospective observational data. The line at 1.00 represents no association. The graphic shows associations and not a causally proven life extension: whoever trains is no different from whoever. The 60 minutes is the value of a separate dose analysis from four studies and is not a target; It doesn't say that more would be harmful. The total sample is not specified in the abstract.

Which physical endpoints controlled studies show

A meta-analysis of randomized trials examined 14 studies in men and women aged 65 years and older. Progressive strength training, sometimes combined with weight-bearing exercises, increased leg strength. The standardized mean difference was SMD 1.10 with a 95% confidence interval of 0.73 to 1.47. A mean difference of 2.77 percent with a 95% confidence interval of 0.44 to 5.10 was reported for femur and hip bone mineral density. The total sample and a common program duration are not specified in the abstract. Overall, the evidence on bone density was significantly more heterogeneous than the evidence on strength. The positive femur and hip findings are therefore a site-specific intermediate endpoint and not a direct lifespan endpoint.

The bone density findings were site-specific. For the lumbar spine, the change was not significant: MD 1.60 percent, 95% confidence interval −1.44 to 4.63, p = 0.30. The heterogeneity was very high at I²=98.6 percent. Therefore, it cannot be concluded from this meta-analysis that strength training improves every bone density in every part of the body.

Why these results do not prove life extension

The findings answer different questions. The mortality data comes primarily from observational studies and shows a statistical association between strength training and mortality. Randomized evidence in older adults shows changes in leg strength and certain bone endpoints. Neither line of evidence shows that training-related changes in strength or bone density confer later longevity or health.

The studies cited did not examine later independence, freedom from dementia, or mediation for survival as a result of an increase in strength or bone density. Such an increase is therefore not direct evidence of these endpoints.

What can be derived for practice

If the goal is the endpoints measured in the controlled trials, progressive resistance training in adults aged 65 years and older is the directly studied option. However, an exact combination of frequency, volume, load and program duration cannot be derived as a general rule from the information available. The training characteristics examined did not influence both outcomes equally, and the program lengths were heterogeneous.

The indication of approximately 60 minutes per week can be reported as an observed pattern in the mortality analysis, not as a target for longevity. The smaller risk reductions observed at higher volumes also show that more training is not automatically better in this data.

What remains open in the bodybuilding context

The studies do not examine natural or competitive bodybuilding, extreme muscle mass, very high calorie or protein intake, or anabolic-androgenic steroids. There is therefore no direct comparison between a health-oriented muscular average and competitive extremes. From this data, neither a shortening of life as a result of such protocols nor a longevity advantage of a particular body type can be derived. At the same time, the missing comparative data is not proof of safety.

Which common longevity levers remain open here

For sleep, nutritional quality, protein, smoking cessation, alcohol, social relationships or stress management, there is no direct causal evidence of an effect on healthspan or lifespan in the sources used here. This does not mean that these factors are ineffective, but rather that no reliable long-term effect can be derived from the proven studies.

Molecular terms such as mitochondrial health, oxidative stress, autophagy, AMPK, mTOR and inflammation are also not proven here as validated surrogates for later healthspan or lifespan endpoints. A plausible biological explanation does not replace evidence in humans.

Classification

The most viable conclusion is limited but practically relevant: lifespan and healthspan are not the same thing. Strength training is associated with lower mortality in mostly observational data, and randomized trials in older adults show improvements in leg strength and femoral and hip bone density. However, the null finding in the lumbar spine, the high heterogeneity of the BMD evidence, the heterogeneous follow-up times and the lack of direct lifespan or healthspan endpoints prevent a causal longevity guarantee.

This data is not sufficient for a special longevity recommendation in bodybuilding.

Sources

  1. Crimmins EM. Lifespan and Healthspan: Past, Present, and Promise. Gerontologist. 2015. PubMed
  2. Shailendra P et al. Resistance Training and Mortality Risk: A Systematic Review and Meta-Analysis. Am J Prev Med. 2022. PubMed
  3. O'Bryan SJ et al. Progressive Resistance Training for Concomitant Increases in Muscle Strength and Bone Mineral Density in Older Adults: A Systematic Review and Meta-Analysis. Sports Med. 2022. PubMed

This article was created using AI systems. Find out more